Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

A comparison of voluntary and forced exercise in protecting against behavioral asymmetry in a juvenile hemiparkinsonian rat model.

Landers MR, Kinney JW, Allen DN, van Breukelen F.

Behav Brain Res. 2013 Jul 1;248:121-8. doi: 10.1016/j.bbr.2013.04.002. Epub 2013 Apr 15.

PMID:
23597837
2.

Forced exercise before or after induction of 6-OHDA-mediated nigrostriatal insult does not mitigate behavioral asymmetry in a hemiparkinsonian rat model.

Landers MR, Kinney JW, van Breukelen F.

Brain Res. 2014 Jan 16;1543:263-70. doi: 10.1016/j.brainres.2013.10.054. Epub 2013 Nov 13.

PMID:
24239657
3.
4.

Stress reduces the neuroprotective effect of exercise in a rat model for Parkinson's disease.

Howells FM, Russell VA, Mabandla MV, Kellaway LA.

Behav Brain Res. 2005 Dec 7;165(2):210-20. Epub 2005 Sep 12.

PMID:
16159673
6.

Exercise exerts neuroprotective effects on Parkinson's disease model of rats.

Tajiri N, Yasuhara T, Shingo T, Kondo A, Yuan W, Kadota T, Wang F, Baba T, Tayra JT, Morimoto T, Jing M, Kikuchi Y, Kuramoto S, Agari T, Miyoshi Y, Fujino H, Obata F, Takeda I, Furuta T, Date I.

Brain Res. 2010 Jan 15;1310:200-7. doi: 10.1016/j.brainres.2009.10.075. Epub 2009 Nov 10.

PMID:
19900418
7.

Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF.

Cohen AD, Tillerson JL, Smith AD, Schallert T, Zigmond MJ.

J Neurochem. 2003 Apr;85(2):299-305.

8.

Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.

Zheng JS, Tang LL, Zheng SS, Zhan RY, Zhou YQ, Goudreau J, Kaufman D, Chen AF.

Brain Res Mol Brain Res. 2005 Mar 24;134(1):155-61.

PMID:
15790539
9.

BDNF receptor blockade hinders the beneficial effects of exercise in a rat model of Parkinson's disease.

Real CC, Ferreira AF, Chaves-Kirsten GP, Torrão AS, Pires RS, Britto LR.

Neuroscience. 2013 May 1;237:118-29. doi: 10.1016/j.neuroscience.2013.01.060. Epub 2013 Feb 8. Erratum in: Neuroscience. 2013 Sep 5;247:319-20.

PMID:
23396085
10.

Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease.

Lapchak PA, Araujo DM, Hilt DC, Sheng J, Jiao S.

Brain Res. 1997 Nov 28;777(1-2):153-60.

PMID:
9449424
11.

Voluntary running provides neuroprotection in rats after 6-hydroxydopamine injection into the medial forebrain bundle.

Mabandla M, Kellaway L, St Clair Gibson A, Russell VA.

Metab Brain Dis. 2004 Jun;19(1-2):43-50.

PMID:
15214505
12.

Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.

Yuan H, Sarre S, Ebinger G, Michotte Y.

Brain Res. 2004 Nov 5;1026(1):95-107.

PMID:
15476701
13.

Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.

Francardo V, Recchia A, Popovic N, Andersson D, Nissbrandt H, Cenci MA.

Neurobiol Dis. 2011 Jun;42(3):327-40. doi: 10.1016/j.nbd.2011.01.024. Epub 2011 Feb 19.

PMID:
21310234
14.
15.

Protective and restorative effects of magnolol on neurotoxicity in mice with 6-hydroxydopamine-induced hemiparkinsonism.

Chen HH, Lin SC, Chan MH.

Neurodegener Dis. 2011;8(5):364-74. doi: 10.1159/000323872. Epub 2011 Apr 15.

PMID:
21494012
17.

Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.

Silva-Adaya D, Pérez-De La Cruz V, Villeda-Hernández J, Carrillo-Mora P, González-Herrera IG, García E, Colín-Barenque L, Pedraza-Chaverrí J, Santamaría A.

Neurotoxicol Teratol. 2011 Mar-Apr;33(2):303-12. doi: 10.1016/j.ntt.2010.10.002. Epub 2010 Oct 7.

PMID:
20933078
18.

The C-terminal domain of the heavy chain of tetanus toxin given by intramuscular injection causes neuroprotection and improves the motor behavior in rats treated with 6-hydroxydopamine.

Mendieta L, Bautista E, Sánchez A, Guevara J, Herrando-Grabulosa M, Moran J, Martínez R, Aguilera J, Limón ID.

Neurosci Res. 2012 Oct;74(2):156-67. doi: 10.1016/j.neures.2012.08.006. Epub 2012 Sep 1.

PMID:
22967672
19.
20.

Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y, Agrawal AK.

Neurobiol Dis. 2006 May;22(2):421-34. Epub 2006 Feb 9.

PMID:
16480889

Supplemental Content

Support Center